Global Radiotherapy Market will reach USD 8.53 Billion by

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
23
Global Radiotherapy Market will reach USD 8.53 Billion by 2022: Zion Market Research

Sarasota, FL, April 06, 2017 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Radiotherapy Market by Product (External Beam Radiation Therapy, Internal Radiation Therapy, Systemic Radiation Therapy), By Technology  for Prostate Cancer, Breast Cancer,  Lung Cancer, Head & Neck Cancer, Colorectal cancer, Gynecological Cancer, Penile Cancer and Other Cancer: Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 - 2022” . According to the report,  global Radiotherapy Market  was valued at approximately USD 5.75 billion in 2016 and is expected to generate revenue of around USD 8.53 billion by end of 2022, growing at a CAGR of around 6.8% between 2017 and 2022. 

Radiotherapy is a treatment for cancer that uses radiation, usually X-rays, to treat illness. Radiotherapy is also sometimes used to treat benign tumors and other conditions, such as thyroid disease and some blood disorders. Radiotherapy is used alone or in combination with chemotherapy (chemoradiotherapy) to treat cancer. Radiotherapy is effective in controlling symptoms of cancer. Radiotherapy may be used before surgery or after surgery to destroy small tumor cells that may be left. Radiotherapy can be external, internal or systemic.

Browse through 42 Market Tables and 46 Figures spread through 110 Pages and in-depth TOC on “Global Radiotherapy Market by Technology, Size & Share- Forecast 2016 – 2022”.

Request Free Sample copy of Radiotherapy Market Report @ https://www.zionmarketresearch.com/sample/rad...apy-market

Global radiotherapy market is primarily driven by growing incidences of cancer across the globe. Other major driving factors are increasing geriatric population and large government funding. However, lack of infrastructure and lack of skilled personnel and training are the major restraints that may limit the growth of the market. Nonetheless, technological advancements in radiotherapy products coupled with a huge investment in radiotherapy across the globe are likely to disclose the new avenues for radiotherapy market in the near future.

The radiotherapy market is segmented on the basis of different products including external beam radiation therapy, internal radiation therapy (brachytherapy), and systemic radiation therapy. External beam radiation therapy is further sub-segmented into compact advanced radiotherapy systems (Cyberknife, Gamma knife, and Tomotherapy), proton therapy systems (Cyclotron and Synchrotron) and electron emitting high energy linear accelerators (Linac). Internal radiation therapy is further sub-classified into seeds, applicators & after leaders and electronic brachytherapy. External beam radiation therapy holds a maximum share of global radiotherapy market.

Browse the full " Radiotherapy Market by Product (External Beam Radiation Therapy, Internal Radiation Therapy, Systemic Radiation Therapy), By Technology  for Prostate Cancer, Breast Cancer,  Lung Cancer, Head & Neck Cancer, Colorectal cancer, Gynecological Cancer, Penile Cancer and Other Cancer: Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 - 2022 " report at  https://www.zionmarketresearch.com/report/rad...apy-market

Based on technology radiotherapy market is classified into external beam radiation therapy (Image-Guided Radiotherapy (IGRT), Intensity Modulated Radiotherapy (IMRT), Stereotactic Technology, Proton Beam Therapy, Tomotherapy, 3D Conformal Radiotherapy (3D CRT) and Volumetric Modulated Arc Therapy (VMAT)), internal radiation therapy (Low Dose Rate and High Dose Rate), and systemic radiation therapy.

Based on applications external beam radiation therapy segment is classified into prostate cancer, breast cancer, lung cancer, head & neck cancer, colorectal cancer and other. Internal radiation therapy is classified into prostate cancer, gynecological cancer, breast cancer, penile cancer and other.

North America represents developed regional markets for radiotherapy and is expected to see the rapid growth in the years to come. The U.S. is by far the leading radiotherapy market by country in North America. The U.S. market is expected to grow at the highest CAGR during the forecast period. This growth is mainly due to the well-developed healthcare infrastructure and increases in research and development on radiotherapy products. Moreover, the disposable income and reimbursement of life-threatening diseases are very high in this region which promotes the growth of radiotherapy market. 

Inquire more about this report before purchase @ https://www.zionmarketresearch.com/inquiry/ra...apy-market

Europe was the second largest regional market and is expected to show significant growth in the years to come. This growth is mainly due to increase in a number of patients diagnosed with cancer.

Asia-Pacific is expected to witness noticeable growth in the near future. In Asia, China, India, and Japan will continue to be the fastest growing markets in radiotherapy market. Growth in Asia-Pacific market is expected to be driven by increasing tobacco consumption, growing population, large geriatric population base and increasing disposable income.

Request customized copy of report @ https://www.zionmarketresearch.com/custom/1296

In Middle East & Africa; African region is projected to register moderate growth rate due to lack of awareness. Latin America is another important regional market and is expected to experience moderate growth over the forecast period. Thus, all the aforementioned parameters are expected to propel the market growth in this region.

Some of the key players in radiotherapy market include Elekta AB, Varian Medical Systems, Accuray Incorporated, IBA Worldwide, IsoRay Medical, Inc., Nordion, Inc., Raysearch Laboratories, Mevion Medical Systems, Mitsubishi Electric Corporation and C. R. Bard, Inc. among others.

For media inquiry contact our sales team @ sales@zionmarketresearch.com

This report segments the global Radiotherapy market as follows:

Global Radiotherapy Market: By Product

  • External beam radiation therapy
  • Compact Advanced Radiotherapy Systems
    • Cyberknife
    • Gamma Knife
    • Tomotherapy
  • Proton Therapy Systems
    • Cyclotron
    • Synchrotron
  • Electron Emitting High Energy Linear Accelerators (Linac)
  • Internal Radiation Therapy/Brachytherapy
    • Seeds
    • Applicators & Afterloaders
    • Electronic Brachytherapy
  • Systemic Radiation Therapy

Global Radiotherapy Market: By Technology

  • External Beam Radiation Therapy
    • Image-Guided Radiotherapy (IGRT)
    • Intensity Modulated Radiotherapy (IMRT)
    • Stereotactic Technology
    • Proton Beam Therapy
    • Tomotherapy
    • 3D Conformal Radiotherapy (3D CRT)
    • Volumetric Modulated Arc Therapy (VMAT)
  • Internal Radiation Therapy
    • Low Dose Rate
    • High Dose Rate
  • Systemic Radiation Therapy

Global Radiotherapy Market: By Application

  • External Beam Radiation Therapy
    • Prostate Cancer
    • Breast Cancer
    • Lung Cancer
    • Head & Neck Cancer
    • Colorectal Cancer
    • Other
  • Internal Radiation Therapy
    • Prostate Cancer
    • Gynecological Cancer
    • Breast Cancer
    • Penile Cancer
    • Other

Global Radiotherapy Market: By Region

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

Related Reports:

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research

Follow Us Twitter:   https://twitter.com/zion_research

Contact Us: Joel John 4283, Express Lane, Suite 634-143, Sarasota, Florida 34249, United States Tel: +49-322 210 92714 USA/Canada Toll-Free No.1-855-465-4651 Email: sales@zionmarketresearch.com Website: https://www.zionmarketresearch.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PMET's High-Stakes Call on Shaakichiuwaanaan Update

Updated Category News Views 51

Inside PMET Resources' Critical Investor Briefing Now, this is the kind of investor chatter that cuts to the core of PMET's game plan. We're talking the big guns coming out with PMET Resources (TSX: PMET) as they gear up for what's poised to be a tell-all investor teleconference about their Shaakichiuwaanaan Project. Yep, mark your calendars because on Tuesday, November...

Continue Reading
Elong Kicks Off Central Asia Strategy with Almaty Launch

Updated Category News Views 70

Elong's Strategic Move into Central Asia When a company like Elong Hotel Technology decides to plant its flag in Central Asia, it’s more than just another overseas venture. This brand launch in Almaty is a bold statement—a signal that they're here to shake things up in a region ripe for development but lacking in hotel chains. With only about 20% penetration for local...

Continue Reading
Jubilant Eyes MPN Breakthrough with JBI-802 Data at ASH

Updated Category News Views 68

Presenting the Case for JBI-802 From the bustling circus of drug development, here comes Jubilant Therapeutics, strutting their stuff with JBI-802, a dual inhibitor designed to tackle myeloproliferative neoplasms (MPNs) with a one-two punch. Now, they're set to drop some spicy deets at the 68th ASH Annual Meeting in New Orleans this December. So what's the fuss about?...

Continue Reading
myKaarma's Off-Site Wash: A Game Changer for Dealers

Updated Category News Views 37

myKaarma Offers Time and Convenience Boost with Wash Option When was the last time a car dealership didn't have folks lined up waiting for a wash? Dragging out your car's service longer than a Sunday sermon. But today, myKaarma, the folks behind dealership customer interaction magic, cracked open another bottle of convenience with their latest offering: off-site,...

Continue Reading
Lyons Steers Home Services Brands to New Franchise Heights

Updated Category News Views 87

Big Changes Ahead for Home Franchise Concepts It's a fresh dawn over at Home Franchise Concepts, and Cory Lyons has been tapped to lead four pivotal brands as their new Brand President. Now, if you're looking at this lineup—Kitchen Tune-Up, Bath Tune-Up, The Tailored Closet, and PremierGarage—you know there's more than just nails and hammers involved. Lyons isn't just...

Continue Reading
Dixie Group Gears Up for Q3 Earnings Call Reveal

Updated Category News Views 105

Anticipation Builds for The Dixie Group's Q3 Results Ah, the smell of anticipation in the air—it's earnings season again, folks! For those keeping a keen eye, The Dixie Group, Inc. (OTCQB: DXYN) sets the stage for the big unveil of its 2026 third-quarter results. They're rolling out the red carpet for investors on Thursday, November 12, 2026, at 11:30 a.m. Eastern Time,...

Continue Reading
MoreBetter's Therapy Co-Investment: A Big Bet on Patient Data

Updated Category News Views 23

Diving Into Uncharted Waters with Bold Moves MoreBetter is stepping right into the murky, unpredictable world of longevity, peptide, and psychedelic therapies with a fresh initiative—the RWE Co-Investment Program. This isn't your run-of-the-mill study announcement; it's a gutsy leap into largely unexplored areas of patient-reported outcomes and real-world evidence. A...

Continue Reading
Mass-Vac Unleashes Advanced Vacuum Protection

Updated Category News Views 92

Introducing a Heavy-Duty Defender for Lab Systems When it comes to safeguarding central laboratory vacuum systems, you can bet there’s more at play than meets the eye. Mass-Vac, Inc., steps up and doesn't mess around with their latest innovation—the MV Multi-Trap® Vacuum Inlet Trap. Climbing aboard in November 2026, this stout guardian against contamination is out to...

Continue Reading
Retail's AI Ambitions Clash with In-Store Data Realities

Updated Category News Views 127

AI's Lofty Goals Meet Retail's Messy Reality I swear, all this chatter about AI transforming retail sounds grand until you dig into the messy trenches, right? This latest Scandit survey lays it bare: retailers have got their AI visions sprinting ahead of the stock data realities inside their stores. Seems those shiny new systems rely on stock data that matches what's...

Continue Reading
Gen Z, Millennials Lean on AI Amid Fiscal Crunch

Updated Category News Views 78

AI Meets Gen Z and Millennials: A Financial Lifeline? Here's an angle you might not expect: young folks are all in for AI, particularly when it comes to navigating banking services. Picture it—18 to 34-year-olds embracing AI far more openly than their older counterparts. We're talking 60% of them valuing 24/7 availability in AI services compared to just 47% of those...

Continue Reading
ws Articles" class="btn" href="https://investorshangout.com/blog/news?page=2">More News Articles